Is the rationale for carotid angioplasty and stenting in patients excluded from NASCET/ACAS or eligible for ARCHeR justified?

PURPOSE To compare outcome after carotid endarterectomy (CEA) in patients who would have been excluded from the North American Symptomatic Carotid Endarterectomy Trial (NASCET) or the Asymptomatic Carotid Atherosclerosis Study (ACAS) or would have been eligible for Acculink for Revascularization of Carotids in High Risk Patients (ARCHeR), a current high-risk stent registry, with outcome in a similar cohort at low risk. METHODS Records of all CEAs performed at our institution from July 1993 to December 2000 were reviewed. Patients were assigned to groups either eligible or ineligible for NASCET and ACAS or ARCHeR, and criteria were stratified according to whether risk was defined by anatomic or medical problems or whether patients were ineligible according to nonmedical protocol exclusion criteria only. RESULTS Preoperative and postoperative data were sufficient to determine risk status according to various study criteria in 857 patients. Stroke or death within 30 days, the primary end point, occurred in 2.1% of patients. Rates were similar in patients excluded from (2.7%) or included in (1.6%) NASCET and ACAS and in patients eligible (3.1%) or ineligible (2.1%) for ARCHeR. Rates did not differ according to whether exclusion or inclusion was based on anatomic risk, medical risk, or protocol exclusion, although trends favored worse outcome in the ARCHeR medical risk subgroup. A higher rate of minor complications was found in the elderly; however, stroke and death rates were similar according to age, gender, repeat procedure, or the presence of contralateral occlusion. CONCLUSIONS No statistically or clinically significant differences were found in combined 30-day stroke or death rates after CEA in any group defined by previous surgical trials or current ongoing high-risk stent registry. While high-risk groups may exist, the premise that operative risk is higher in patients excluded from NASCET and ACAS or eligible for ARCHeR is not supported.

[1]  S. Bailey,et al.  Management of neurological complications of carotid artery stenting. , 2001, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[2]  D. Wirthlin,et al.  High-risk carotid endarterectomy: challenges for carotid stent protocols. , 2002, Journal of vascular surgery.

[3]  D. Sackett,et al.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. , 1991, The New England journal of medicine.

[4]  J M Bland,et al.  Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial , 2001, The Lancet.

[5]  M. Alberts,et al.  Results of a Multicenter Prospective Randomized Trial of Carotid Artery Stenting vs. Carotid Endarterectomy , 2001, Stroke.

[6]  B. Perler.  Carotid endarterectomy: The gold standard , 2002 .

[7]  Systematic Comparison of the Early Outcome of Angioplasty and Endarterectomy for Symptomatic Carotid Artery Disease , 2000 .

[8]  A. Davies,et al.  Endarterectomy for asymptomatic carotid artery stenosis , 1995, BMJ.

[9]  Immediate and Late Clinical Outcomes of Carotid Artery Stenting in Patients With Symptomatic and Asymptomatic Carotid Artery Stenosis A 5-Year Prospective Analysis , 2001 .

[10]  B. Perler.  Carotid endarterectomy: the "gold standard" in the endovascular era. , 2002, Journal of the American College of Surgeons.

[11]  Carotid Angioplasty and Stenting: Are They Therapeutic Alternatives? , 2001, Cerebrovascular Diseases.

[12]  E. Diethrich,et al.  Current status of carotid bifurcation angioplasty and stenting based on a consensus of opinion leaders. , 2001, Journal of vascular surgery.

[13]  K. Ouriel,et al.  Preprocedural risk stratification: identifying an appropriate population for carotid stenting. , 2001, Journal of vascular surgery.

[14]  Adel M. Malek,et al.  Stent Angioplasty for Cervical Carotid Artery Stenosis in High-Risk Symptomatic NASCET-Ineligible Patients , 2000, Stroke.

[15]  A. Buchan,et al.  *North American Symptomatic Carotid Endarterectomy Trial (NASCET) Steering Committee. Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis. , 1991 .

[16]  S. Money,et al.  Influence of NASCET/ACAS trial eligibility on outcome after carotid endarterectomy. , 2001, Journal of vascular surgery.

[17]  Wilfried Lang,et al.  Carotid Artery Stenting: Effect of Learning Curve and Intermediate-Term Morphological Outcome , 2001, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.